CorMedix Completes Acquisition of Heron Therapeutics

CorMedix has completed its acquisition of Heron Therapeutics. Oppenheimer analysts said the deal could support CorMedix’s growth alongside its existing products and contribute positively to its performance outlook in the coming years. The article reports no financial terms or stock-price impact.